ArticleCancer immunology, immunotherapy : CII2021

Immunoscore is a strong predictor of survival in the prognosis of stage II/III gastric cancer patients following 5-FU-based adjuvant chemotherapy.

Sumi Yun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.